Organisation paid for research Program year 2025 Source: CMS Open Payments

Wr-Mount Vernon Clinical

Neither a doctor nor a teaching hospital

Research payments

$375,053

42 payments

Through program year 2025, Wr-Mount Vernon Clinical is reported as receiving $375,053 in research payments, across 42 payments.

By program year

4 rows
Year Kind Amount Payments
2025 Research $103,321 12
2024 Research $204,240 23
2023 Research $67,219 6
2020 Research $273 1

Breakdown

Who paid Research payments · program years 2020–2025
  1. GlaxoSmithKline, LLC. $375,053 42 payments
Studies the money was for Research payments · program years 2020–2025
  1. 17 B-Hydroxysteroid Dehydrogenase Type 13 Minimization for the Treatme $302,787 33 payments
  2. A Phase 3, Open-Label, Randomized, Controlled, Multi Country Study to $37,395 3 payments
  3. A Phase 3, Randomized, Placebo-Controlled, Observer-Blind, Multi-Count $19,401 2 payments
  4. A Phase III, Randomized, Controlled, Observer-Blind Study to Evaluate $15,197 3 payments
  5. A Phase 3 Study to Compare the Efficacy and Safety of Gepotidacin With $273 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record